Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Sandoz Inc., priced at $4.9643 per ML under NDC 61314064710. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Sandoz Inc.NDC
61314064710
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Authorized Generic (NDA)
FDA Application
NDA050592On Market Since
1/2/2009
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 72.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9643 per ML |
|---|---|
| All-time high | $18.2963 (Jan 15, 2014) |
| All-time low | $2.8218 (Nov 20, 2024) |
| 52-week high | $4.9644 |
| 52-week low | $4.1561 |
| Median price | $13.6796 |
| Average price | $11.8218 |
| Largest weekly change | +67.2% (Aug 23, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Sandoz Inc., is $4.9643 per ML (NDC 61314064710), effective Jun 24, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 72.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $2.8218 (Nov 20, 2024) to a high of $18.2963 (Jan 15, 2014), with a median of $13.6796 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOBRAMYCIN-DEXAMETH OPHTH SUSP, is $4.2803 per ML — about 14% below TOBRAMYCIN-DEXAMETH OPHTH SUSP.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 61314064710) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification